{"news_desk": "Business", "print_page": "6", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By MICHAEL J. de la MERCED", "person": [{"middlename": "J.", "firstname": "Michael", "lastname": "de la MERCED", "rank": 1, "role": "reported", "organization": ""}]}, "abstract": "Valeant Pharmaceuticals chief executive J Michael Pearson has been forced by Goldman Sachs to sell almost 1.3 million of his shares in company to cover loan that bank gave him.", "type_of_material": "News", "word_count": "578", "lead_paragraph": "Valeant Pharmaceuticals disclosed that Goldman Sachs sold nearly 1.3 million shares in the drug maker, which were being held as collateral for a loan extended to Valeant\u2019s chief executive.", "pub_date": "2015-11-07T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Valeant&#8217;s Chief Forced to Sell Company Shares He Pledged Against Loans", "print_headline": "Valeant&#8217;s Chief Forced to Sell Company Shares He Pledged Against Loans"}, "snippet": "Valeant Pharmaceuticals disclosed that Goldman Sachs sold nearly 1.3 million shares in the drug maker, which were being held as collateral for a loan extended to Valeant\u2019s chief executive.", "multimedia": [{"height": 126, "url": "images/2015/10/27/business/27valeant/27valeant-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/10/27/business/27valeant/27valeant-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 395, "url": "images/2015/10/27/business/27valeant/27valeant-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "395", "xlarge": "images/2015/10/27/business/27valeant/27valeant-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/10/27/business/27valeant/27valeant-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/10/27/business/27valeant/27valeant-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/07/business/dealbook/valeants-chief-forced-to-sell-company-shares-he-pledged-against-loans.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Goldman Sachs Group Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Pearson, John Michael (1959- )", "name": "persons"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "563d529938f0d82a02cd2a95", "source": "The New York Times"}